Phillips-Medisize, a Molex company known for its expertise in medtech and drug delivery device manufacturing, has launched TheraVolt™ Medical Connectors, marking its first branded connector platform for healthcare applications. TheraVolt represents a significant innovation in medical connectivity, engineered to support both signal and high-voltage lines within compact, high-density configurations. As electrophysiology (EP) and pulsed field ablation (PFA) therapies rapidly evolve, TheraVolt meets the growing need for reliable, miniaturized connectors that enable more advanced and multifunctional treatment devices.
TheraVolt is designed to offer enhanced cross-platform compatibility, empowering device engineers with the flexibility to integrate more complex features without increasing the device footprint. Key features include high pin count capacity, high voltage clearance, sterilization compatibility, and tailored design options—making it ideal for EP systems, especially those treating atrial fibrillation. The connector's ability to withstand repeated autoclave cycles ensures durability in clinical environments, while its customizable configurations reduce development time and streamline integration into capital equipment and disposable systems alike.
This launch not only reflects Phillips-Medisize’s commitment to driving innovation in next-generation medical technology but also leverages over 80 years of Molex’s leadership in interconnect solutions. By combining electrical performance with mechanical reliability, TheraVolt helps medical device companies accelerate product development, lower costs, and deliver safer, more efficient treatments. With additional connectors in the pipeline, Phillips-Medisize is positioned to play a leading role in shaping the future of device connectivity in a rapidly advancing medtech landscape.
MedTech Spectrum's Summary
Next-Gen Connectivity for Advanced Therapies: TheraVolt supports high pin counts and high-voltage lines, enabling the integration of complex functions in compact devices—especially valuable in electrophysiology and pulsed field ablation systems.
Customizable, Durable, and Compliant: Designed for sterilization, regulatory compliance, and tailored configurations, TheraVolt reduces development time while ensuring safety, reliability, and longevity in clinical use.
Strategic Expansion in Medtech Integration: As Phillips-Medisize’s first branded connector, TheraVolt positions the company to lead in medical device innovation by uniting Molex’s connectivity expertise with medtech manufacturing excellence.
